Therapeutic Advances in Hematology
SAGE PUBLICATIONS LTD · United States
Metrics
- Impact factor
- 2.8-0.3 Clarivate JCR
- WoS quartile
- Q2 Clarivate JCR, best category
- SJR
- 1.018Q1 SCImago
- h-index
- 41
- CAS tier
- Tier 2 Chinese Academy of Sciences
- Citations per paper
- 2.63 last 2 years
- Articles per year
- 54
- Self-citation
- 0%
- Fee (APC), est.
- $3,317 estimated, check the journal
About this journal
- ISSN
- 2040-6207 (print) · 2040-6215 (online)
- Publisher
- SAGE PUBLICATIONS LTD · SAGE
- Country
- United States · Western Europe
- Indexed in
- SCIE
- Access
- Gold OA · 100% gold OA
- Original research
- 57.8%
- Subject areas
- Medicine
- Categories
- Hematology
- Common topics
- Medicine, Internal medicine, Biology, Genetics, Immunology
Similar journals
- Q2WoS
Journal of Physical Chemistry B
Impact factor 3.2h-index 363SJR 0.79 - Q2WoS
Journal of Cell Biology
Impact factor 6.1h-index 353SJR 3.27 - Q2WoS
Journal of Immunology
Impact factor 4h-index 345SJR 1.44 - Q2WoS
Langmuir
Impact factor 4.4h-index 300SJR 0.76 - Q2WoS
Human Molecular Genetics
Impact factor 3.1h-index 255SJR 1.45 - Q2WoS
Journal of Nutrition
Impact factor 4.2h-index 240SJR 1.21
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals